Deux cas de zona atypique chez des personnes prenant des inhibiteurs de Janus kinases par voie orale

CMAJ. 2024 Sep 30;196(32):E1125-E1128. doi: 10.1503/cmaj.240221-f.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Aged
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use
  • Female
  • Herpes Zoster* / diagnosis
  • Herpes Zoster* / drug therapy
  • Humans
  • Janus Kinase Inhibitors* / administration & dosage
  • Janus Kinase Inhibitors* / adverse effects
  • Janus Kinase Inhibitors* / therapeutic use
  • Male
  • Middle Aged
  • Piperidines
  • Pyrazoles / administration & dosage
  • Pyrazoles / adverse effects
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects

Substances

  • Janus Kinase Inhibitors
  • Pyrimidines
  • Antiviral Agents
  • Pyrazoles
  • tofacitinib
  • Piperidines